|
|
Volumn 3, Issue 1, 2001, Pages 33-40
|
|
Chemotherapy for advanced or recurrent carcinoma of the cervix.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ADULT;
AGED;
CANCER INVASION;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
FEMALE;
HUMAN;
MIDDLE AGED;
MORTALITY;
PATHOLOGY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
RISK ASSESSMENT;
SQUAMOUS CELL CARCINOMA;
SURVIVAL;
TREATMENT OUTCOME;
TUMOR RECURRENCE;
UTERINE CERVIX TUMOR;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
FEMALE;
HUMANS;
MIDDLE AGED;
NEOPLASM INVASIVENESS;
NEOPLASM RECURRENCE, LOCAL;
NEOPLASM STAGING;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIALS;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
UTERINE CERVICAL NEOPLASMS;
|
|
EID: 18344375344
PISSN: 15233790
EISSN: None
Source Type: Journal
DOI: 10.1007/s11912-001-0040-5 Document Type: Review |
|
Times cited : (2)
|
|
References (111)
|
